Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
How To Capture Growth In The Expanding Metabolic Drug Market
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
What's Next In Pharmaceutical R&D?
Emerging R&D trends focus on novel pulmonary and nasal delivery methods. Solubility remains a key challenge, addressed through techniques like microfluidics for nanosuspensions.
-
How One Biotech Company Is Accelerating The Drug Discovery Workflow
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
-
Advanced Therapies Going Mainstream: Are We There Yet?
Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.
-
Patient-Centric Formulations In Pediatric Adherence
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
Cell Culture Media Mixing In A Benchtop Single-Use Mixer
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Assessing Particle Generation In A Single-Use Mixing System
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Your Guide To Precise And Robust Separation Methods
Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.
-
Simplify Cell Line Development
A streamlined workflow combining microfluidic dispensing and multimodal imaging enables efficient single-cell isolation, viability assessment, and outgrowth analysis to support cell line development.
-
A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics
Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.
FORMULATION DEVELOPMENT SOLUTIONS
- Inhaled Product Development
- Keep A Close Eye On Quality With Excipients For Drug Formulation
- Granulated Materials: Easy Handling For Improved Process Efficiency
- Addressing Your Requirements For Parenteral Applications
- Resin Offering High Productivity And Robust Processes
- Chromatography Consultation Tools For Process Intensification
- The Buyer's Guide To Buffer Formulation Equipment
- Accelerate Molecules Through Development With Translational Pharmaceutics®
- PBPK Predictive Modeling Services
- Increase Speed, Sensitivity, And Resolution With UPLC Column Technology
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- Techceuticals Announces 2026 Solid Dosage Manufacturing Process Training Schedule
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- Large-Capacity Double Planetary Mixer Ideal For Highly Viscous Materials
- CSL To Build Out U.S. Plasma Capabilities Through $1.5B Investment
- Equipment Auction Announced For Sutro Biopharma Assets
- Syntegon Delivers Strong Growth And Margin Expansion In Q3 2025 With Accelerating Pharma Momentum And Profitability Gains Across All Segments
- Novartis To Add Small Molecule & Fill/Finish Capacity With North Carolina Drug Manufacturing Investments
- Halozyme Completes Acquisition Of Elektrofi, Expanding Breadth Of Offerings In Drug Delivery
- Regeneron Announces Plans To Establish New Drug Manufacturing Facility In Saratoga Springs NY
- Novartis Expands U.S. footprint With New Radioligand Therapy Facility In California